What is the clinical evidence from this study?

Study design: Review. Population: Cardiovascular disease, Myocardial infarction, Heart failure. Intervention: Heart rate variability (HRV) measurement.

What question did this study set out to answer?

To review the relationship between heart rate variability (HRV) and cardiovascular disease risk, focusing on prognostic stratification for mortality and fatal arrhythmias in acute myocardial infarction and heart failure.

January 1, 2014Journal of Korean DiabetesOpen Access

Heart Rate Variability and the Risk of Cardiovascular Disease

View Full Paper

Ask AI

Bookmark

Key result

Reduced heart rate variability is associated with an increased risk of mortality and fatal arrhythmias in patients after acute myocardial infarction or with heart failure.

Why the study?

Does heart rate variability (HRV) measurement predict mortality and arrhythmias in patients with acute myocardial infarction or heart failure?

Key Points

To review the relationship between heart rate variability (HRV) and cardiovascular disease risk, focusing on prognostic stratification for mortality and fatal arrhythmias in acute myocardial infarction and heart failure.
Synthesized findings from clinical cohorts and trials assessing time-domain, frequency-domain, and non-linear HRV parameters across cardiovascular and metabolic conditions.
Evaluated outcomes across post-infarction and heart failure cohorts, including the MPIP trial with an average follow-up of 31 months, the ATRAMI study, and the UK-Heart study.
In the MPIP cohort over an average 31-month follow-up, an SDNN below 50 ms was associated with a 5.3-fold higher mortality compared to an SDNN of 100 ms or greater.
In the UK-Heart study of heart failure patients, annual mortality was 51.4% when SDNN was under 50 ms versus 5.5% when SDNN was greater than 100 ms.
HRV assessment conducted late after acute myocardial infarction (> 6 wks) better predicts sudden cardiac death and fatal arrhythmia than early-phase assessment within 2 weeks.

Structured PICO

Does heart rate variability (HRV) measurement predict mortality and arrhythmias in patients with acute myocardial infarction or heart failure?

Population

Patients with acute myocardial infarction (AMI) or heart failure

Intervention

Heart rate variability (HRV) measurement

Outcome

Mortality, sudden cardiac death, and fatal arrhythmiashard clinical

HRV is a useful non-invasive tool for risk stratification of cardiovascular mortality and arrhythmias in patients with AMI and heart failure, though optimal timing and cut-offs require further standardization.

Limitations

Heart rate variability measurement has a relatively low positive predictive value for mortality risk.
There is a lack of consensus on the appropriate cut-off values for defining abnormal heart rate variability.
Heart rate variability is influenced by many confounding factors, including patient diversity and the use of medications such as beta-blockers.
Low positive predictive value of HRV alone
Lack of consensus on optimal cut-off values for abnormal HRV
Confounding effects of medications such as beta-blockers
Decreased overall mortality in the modern AMI era makes statistical significance harder to prove

Implication

May support risk stratification in post-MI and HF patients; leaves open standardization of HRV timing and cut-offs.

Abstract

The Journal of Korean Diabetes (Heart Rate Variability; HRV) . HRV . 24 , PubMed 17,000

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2014) conducted a review in Cardiovascular disease, Myocardial infarction, Heart failure. Heart rate variability (HRV) measurement was evaluated. Reduced heart rate variability is associated with an increased risk of mortality and fatal arrhythmias in patients after acute myocardial infarction or with heart failure.

synapsesocial.com/papers/6a1d70b633e2df9c962f8538 https://doi.org/10.4093/jkd.2014.15.4.211

Topics

Cardiovascular prevention

View Full Paper

Ask AI

Bookmark

Implication

May support risk stratification in post-MI and HF patients; leaves open standardization of HRV timing and cut-offs.

Abstract

The Journal of Korean Diabetes (Heart Rate Variability; HRV) . HRV . 24 , PubMed 17,000

Heart Rate Variability and the Risk of Cardiovascular Disease

Key Points

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Topics

Heart Rate Variability and the Risk of Cardiovascular Disease

Key Points

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Keep reading

Topics

Keep reading